Jessica Grossman, M.D., is the CEO of Medicines360, a novel mission-based drug device company. Dr. Grossman also serves on the Board of Directors of Dare Biosciences. Previously, she served as founding President and CEO of Sense4Baby, Inc. and was also Founder and President of Gynesonics, a medical device company focused on minimally invasive solutions for women’s health. Under her leadership, she developed the first intrauterine ultrasound guided radiofrequency ablation device for fibroid tumors. In addition to raising more than $50M over the course of her career, Dr. Grossman holds 11 issued patents and has published several peer reviewed articles. She earned her M.D. degree at Thomas Jefferson University and graduated with honors from Brandeis University for her undergraduate degree.